Clinical Trials
4 trialsNCT07560410 2026-05-11
Treatment of Truncated ALK-positive Bone Cancer Using Crizotinib (Xalkori) or Alectinib (Alecensa)
China Medical University Hospital
Phase 1/2 Not yet recruiting
NCT05395741 2026-03-25
Regbone
Institute of Mother and Child, Warsaw, Poland
Phase 1/2 Active not recruiting
NCT03965234 2026-03-17
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
Roswell Park Cancer Institute
Phase 1/2 Recruiting
NCT06562673 2025-12-29
IACE-OS
Shanghai 6th People's Hospital
Phase 1/2 Completed